References
- Melekos MD, Naber K. Complicated urinary tract infec-tions. Int J Antimicrob Agents 2000; 15: 247–256.
- Nicolle LE. Epidemiology of urinary tract infections. Infect Med 2001; 18: 153–162.
- Ruben FL, Dearwater ST, Norden CW. Clinical infec-tions in the non-istituzionalized geriatric group: methods uti-lized and prevalence of infections. Am J Epidemiol 1995; 141: 145–157.
- Privitera G, Visona' G, Porretta A, Panceri L, Marchetti F. Epidemiologia e modalita' di gestione delle infezioni bat-teriche nei servizi di pronto soccorso degli ospedali italiani. Atti del 39mo Congresso Nazionale della Societa Italiana di Igiene, Ferrara, 24-25 settembre 2000.
- Bosisio V, Stella R, Castagna S, Marchetti F. A prospec-tive, descriptive study on the practise of management of uri-nary tract infections by general pratictioners in Italy: epidemi-ology (Part I). Archivio Italiano di Urologia e Andrologia 2003; 75 (2): 9–12.
- Rizzo M, Marchetti F, Travaglini F, Trinchieri A, Nickel JC. Prevalence, diagnosis and treatment of prostatitis In Italy: a prospective observational urology outpatient practice study. British J Urol Int 2003; 92: 955–959.
- Frea B. La gestione ambulatoriale delle infezioni urinarie in Italia: aspetti epidemiologici, diagnostici e terapeutici. Studio multicentrico nazionale. Atti del 74mo Congresso Nazionale Societa Italiana di Urologia, Cagliari, 12-18 giugno 2001.
- Foxman B. Epidemiology of urinary tract infections: inci-dence, morbidity and economic costs. Am J Med 2002; 113 (1A): 5S-13S.
- Warren W, Abrutyn E, Hebel R, Johnson J, Schaeffer A, Stamm W. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999; 29: 745–58.
- Naber K, Bergman B, Bishop MC, et al. EAU Guidelines for the management of urinary and male genital tract infections. Eur Urolol 2001; 40: 576–588.
- Rubin RH, Shapiro ED, Andriole VT, Davies RJ, Stamm WE. General guidelines for the evaluation of new anti-infective drugs for the treatment of urinary tract infections. Clin Infect Dis 1992; 15 (Suppl 1): 216–27.
- Obana Y, Shibata K, Nishimo T, Adherence of Serratia marcescens in the patogênesis of urinary tract infec-tions in diabetic mice. J Med Microbiol 1991; 35: 93–97.
- Bernard AM, Ouled M, Lauwerys RR, Lambert A, Vandeleene R. Pronounced decrease of Tamm-Horsfall pro-teinuria in diabetics. Clin Chem 1987; 33: 1624.
- Schito GC, Chezzi C, Nicoletti G, et al. Susceptibility of frequent urinary pathogens to fosfomycin trometamol and eight other antibiotics: results of an Italian multicentre survey. Infection 1992; 20 (Suppl 4): S291–S295.
- Marchese A, Gualco L, Debbia E, Schito GC, Schito AM. In vitro activity of fosfomycin against Gram-negative uri-nary pathogens and the biological cost of fosfomycin resis-tance. Int J Antimicrob Agents 2003; 22: S53–S59.
- Gesu GP, Marchetti F, Piccoli L, Cavallero A. Levofloxacin and ciprofloxacin in vitro activity on 4003 bacte-rial clinical isolates collected in 24 Italian laboratories. Antimicrob Agents Chemother 2003; 47 (2): 816–819.